Why the study?
The explanation for sex-related differences in HFrEF experience, including poorer quality of life and suboptimal treatment in women despite living longer, is unknown.
Women with HFrEF face significant sex-related disparities, experiencing worse quality of life and receiving suboptimal treatment compared to men despite having longer survival.
Answers are grounded in this paper and cite their sources.
Warrants clinical attention to QoL and treatment gaps in women with HFrEF; leaves open whether sex-specific strategies improve outcomes.
Although women with HFrEF live longer than men, their additional years of life are of poorer quality, with greater self-reported psychological and physical disability. The explanation for this different sex-related experience of HFrEF is unknown as is whether physicians recognize it. Women continue to receive suboptimal treatment, compared with men, with no obvious explanation for this shortfall.
No takes yet. Share an insight, caveat, or question.
Dewan et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: